UroGen Pharma Ltd.
URGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001668243
In the last 90 days, UroGen Pharma Ltd. insiders filed 0 open-market purchases and 4 sales; 190 institutions reported holding it in 13F filings for Q2 2026, worth $1.56B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2023
Institutional positions in UroGen Pharma Ltd. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +4 vs. Q3 2023
- Shares held
- 21.4M
- +3.68M (+20.8%) vs. Q3 2023
- Total value
- $321.2M
- +$72.8M (+29.3%) vs. Q3 2023
- New holders
- 16
- 50 more added
- Sold out
- 12
- 18 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting URGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 190 | $1.56B |
| Q1 2026 | 173 | $835.2M |
| Q4 2025 | 167 | $1.02B |
| Q3 2025 | 161 | $878.6M |
| Q2 2025 | 150 | $545.2M |
| Q1 2025 | 140 | $460.6M |
| Q4 2024 | 138 | $386.3M |
| Q3 2024 | 128 | $445.7M |
| Q2 2024 | 115 | $641.4M |
| Q1 2024 | 112 | $407.4M |
| Q4 2023 | 105 | $321.2M |
| Q3 2023 | 101 | $248.3M |
| Q2 2023 | 85 | $137.8M |
| Q1 2023 | 66 | $116.1M |
| Q4 2022 | 64 | $115.4M |
| Q3 2022 | 60 | $110.8M |
| Q2 2022 | 65 | $109.2M |
| Q1 2022 | 84 | $123.9M |
| Q4 2021 | 78 | $140.4M |
| Q3 2021 | 93 | $236.9M |
| Q2 2021 | 82 | $213.7M |
| Q1 2021 | 89 | $278.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding UroGen Pharma Ltd.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 1,719,304 | $25.8M | 0.00% | +521,657+43.6% | Added |
| RTW Investments, LP | 1,726,808 | $25.9M | 0.40% | +869,344+101.4% | Added |
| Menora Mivtachim Holdings Ltd. | 2,303,031 | $34.5M | 0.29% | 00.0% | Unchanged |
| Great Point Partners LLC | 2,620,545 | $39.3M | 6.70% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 3,083,430 | $46.3M | 0.72% | +1,599,733+107.8% | Added |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −372,000−100.0% | Sold out |
| Clal Insurance Enterprises Holdings Ltd | 0 | $0 | 0.00% | −222,159−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −170,523−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −17,017−100.0% | Sold out |
| Denali Advisors LLC | 0 | $0 | 0.00% | −14,300−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −10,189−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −5,941−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −4,563−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −2,048−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −1,567−100.0% | Sold out |
| West Tower Group, LLC | 0 | $0 | 0.00% | −354−100.0% | Sold out |
| Carmel Capital Partners, LLC | 0 | $0 | 0.00% | −259−100.0% | Sold out |